Table 1.
Combination | DTP ± SD by days of exposure at growth stage shownb: |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A5 |
H5 |
H12 |
H19 |
|||||||||
7 | 14 | 21 | 7 | 14 | 21 | 7 | 14 | 21 | 7 | 14 | 21 | |
Control | 2 ± 1 | 2 ± 1 | 2 ± 1 | 3 ± 1 | 3 ± 1 | 4 ± 1 | 3 ± 1 | 4 ± 2 | 5 ± 1 | 4 ± 1 | 5 ± 1 | 5 ± 1 |
R-I-Z-E | 20 ± 4 | 27 ± 3 | >100 | 19 ± 1 | 23 ± 5 | 24 ± 5 | 15 ± 1 | 26 ± 4 | >100 | 18 ± 3 | 32 ± 10 | >100 |
R-MX-AK | 15 ± 2 | 24 ± 4 | >100 | 16 ± 2 | 23 ± 1 | >100 | 19 ± 2 | 51 ± 4 | >100 | 19 ± 2 | 22 ± 1 | >100 |
R-MX-AK-MZ | 21 ± 7 | 18 ± 3 | >100 | 17 ± 2 | 21 ± 7 | >100 | 19 ± 5 | 28 ± 6 | >100 | 17 ± 2 | >100 | >100 |
R-MX-AK-NZ | 17 ± 3 | 24 ± 3 | >100 | 15 ± 1 | 22 ± 2 | >100 | 16 ± 2 | >100 | >100 | 18 ± 1 | >100 | >100 |
R-MX-AK-NC | 16 ± 2 | 19 ± 2 | 20 ± 1 | 13 ± 2 | 18 ± 1 | >100 | 15 ± 2 | 27 ± 3 | >100 | 19 ± 1 | 27 ± 1 | >100 |
R-MX-AK-PA | 38 ± 8 | >100 | >100 | 26 ± 4 | >100 | >100 | 20 ± 2 | >100 | >100 | 24 ± 4 | >100 | >100 |
Five-day-old aerobic (A5) cultures, and 5-, 12-, and 19-day-old hypoxic (H5, H12, and H19, respectively) cultures were incubated with various combinations of drugs for 7, 14, and 21 days. R, rifampin; I, isoniazid; Z, pyrazinamide; E, ethambutol; AK, amikacin; MX, moxifloxacin; MZ, metronidazole; NZ, nitazoxanide; NC, niclosamide; PA, PA-824. The drug concentrations used were 8, 2, 100, 4, 8, 4, 8, 10, 0.3, and 2 μg/ml, respectively.
Means ± standard deviations from three experiments are shown.